Accelerated three-dimensional conformal radiotherapy for early-stage glottic cancer in reducing dose to the internal carotid artery and pharyngeal constrictor muscles

被引:0
作者
Tomizawa, Kento [1 ]
Motegi, Atsushi [1 ]
Oyoshi, Hidekazu [1 ]
Fujisawa, Takeshi [1 ]
Zenda, Sadamoto [1 ]
Zhou, Yuzheng [1 ]
Nakamura, Masaki [1 ]
Hirata, Hidenari [1 ]
Hojo, Hidehiro [1 ]
Kageyama, Shun-ichiro [1 ]
Hirotaki, Kouta [2 ]
Matsuura, Kazuto [3 ]
Akimoto, Tetsuo [1 ]
机构
[1] Natl Canc Ctr Hosp East, Dept Radiat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East, Dept Radiol Technol, Kashiwa, Japan
[3] Natl Canc Ctr Hosp East, Dept Head & Neck Surg, Kashiwa, Japan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2024年 / 46卷 / 02期
关键词
3D-CRT; alternative fraction; carotid artery; glottis cancer; pharyngeal constrictor muscle; CARCINOMA; HEAD; STENOSIS; T1N0;
D O I
10.1002/hed.27568
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background We evaluated clinical and dosimetric outcomes of radiotherapy using two anterior oblique portals (AOP), to reduce the dose to the bilateral internal carotid arteries (CAs) and pharyngeal constrictor muscle (PCM) during early-stage glottic cancer (ESGC) treatment.Methods We identified patients with ESGC who underwent definitive radiotherapy between June 2014 and May 2020.Results Among the 66 patients, 32 (48%) underwent radiotherapy using AOP, and the remaining underwent typical radiotherapy using parallel opposed lateral portals (POLP). The median follow-up duration was 53 months. No significant differences were observed in the 5-year local failure (0%/9.4%), progression-free survival (90.6%/90.8%), and overall survival (90.6%/91.0%) rates between the two groups. The grade >= 2 acute mucositis incidence rate was significantly lower in the AOP group (44%/85%). Radiotherapy using AOP maintained an adequate dose coverage to the target while markedly reducing the CAs and PCM doses.Conclusion Radiotherapy with AOP resulted in favorable clinical and dosimetric outcomes.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 20 条
[1]   Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer [J].
Amini, Arya ;
Morgan, Rustain ;
Meyer, Elisabeth ;
Fakhoury, Kareem ;
Ladbury, Colton ;
Bickett, Thomas ;
McDermott, Jessica D. ;
Stokes, William ;
Karam, Sana D. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11) :3393-3403
[2]   Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007 [J].
Bicakci, Beyhan Ceylaner ;
Mustafayev, Teuta Zoto ;
Cetinayak, Oguz ;
Igdem, Sefik ;
Birgi, Sumerya Duru ;
Meydan, Deniz ;
Demircioglu, Fatih ;
Atalar, Banu ;
Ozyar, Enis ;
Akman, Fadime .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (08) :1825-1832
[3]   A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies [J].
Brown, PD ;
Foote, RL ;
McLaughlin, MP ;
Halyard, MY ;
Ballman, KV ;
Collie, AC ;
Miller, RC ;
Flemming, KD ;
Hallett, JW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05) :1361-1367
[4]   T1N0 TO T2N0 SQUAMOUS CELL CARCINOMA OF THE GLOTTIC LARYNX TREATED WITH DEFINITIVE RADIOTHERAPY [J].
Chera, Bhishamjit S. ;
Amdur, Robert J. ;
Morris, Christopher G. ;
Kirwan, Jessica M. ;
Mendenhall, William M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02) :461-466
[5]   Dysphagia after definitive radiotherapy for head and neck cancer Correlation of dose-volume parameters of the pharyngeal constrictor muscles [J].
Deantonio, L. ;
Masini, L. ;
Brambilla, M. ;
Pia, F. ;
Krengli, M. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (03) :230-236
[6]   Carotid dosimetry for T1 glottic cancer radiotherapy [J].
Garcez, K. ;
Lim, C. C. ;
Whitehurst, P. ;
Thomson, D. ;
Ho, K. F. ;
Lowe, M. ;
Sykes, A. ;
Lee, L. W. ;
Yap, B. ;
Slevin, N. .
BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1038)
[7]   Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience [J].
Gowda, RV ;
Henk, JM ;
Mais, KL ;
Sykes, AJ ;
Swindell, R ;
Slevin, NJ .
RADIOTHERAPY AND ONCOLOGY, 2003, 68 (02) :105-111
[8]   Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer [J].
Hong, Chae-Seon ;
Oh, Dongryul ;
Ju, Sang Gyu ;
Ahn, Yong Chan ;
Noh, Jae Myoung ;
Chung, Kwangzoo ;
Kim, Jin Sung ;
Suh, Tae-Suk .
CANCER RESEARCH AND TREATMENT, 2016, 48 (01) :63-70
[9]   Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada [J].
Jackson, LD ;
Groome, PA ;
Schulze, K ;
O'Sullivan, B ;
Irish, JC ;
Dixon, PF ;
Eapen, LJ ;
Gulavita, SP ;
Hammond, JA ;
Hodson, DI ;
Mackenzie, RG ;
Bissett, RJ ;
Schneider, KM ;
Warde, PR ;
Mackillop, WJ .
CLINICAL ONCOLOGY, 2003, 15 (05) :266-279
[10]   Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3) [J].
Kodaira, Takeshi ;
Kagami, Yoshikazu ;
Machida, Ryunosuke ;
Shikama, Naoto ;
Sekino, Yuta ;
Ito, Yoshinori ;
Ishikura, Satoshi ;
Saito, Yoshihiro ;
Matsumoto, Yasuo ;
Konishi, Koji ;
Murakami, Naoya ;
Akimoto, Tetsuo ;
Fukushima, Yuuki ;
Toshiyasu, Takashi ;
Katano, Atsuto ;
Nagata, Yasushi ;
Ogawa, Hirofumi ;
Uno, Takashi ;
Hamamoto, Yasushi ;
Nishimura, Yasumasa ;
Mizowaki, Takashi .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (05) :1118-1124